We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Eyes and Attention Deficit (SEAD)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00472511
First Posted: May 11, 2007
Last Update Posted: July 3, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Ohio State University
  Purpose
Attention-Deficit Hyperactivity Disorder (ADHD) is considered to be one of the most prevalent chronic health conditions in children. It affects between 4% and 12% of young children. A relationship between convergence insufficiency (eye teaming) and ADHD has been shown. However, the effect of ADHD medications on focusing and eye teaming has not been previously investigated. Therefore, the purpose of this study is to determine the effect of ADHD medication on focusing and eye teaming skills.

Condition
ADHD Convergence Insufficiency Accommodative Insufficiency

Study Type: Observational
Study Design: Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Ohio State University:

Estimated Enrollment: 75
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   7 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Best corrected visual acuity of 20/25 in both eyes at distance and near;
  • Willingness to wear eyeglasses or contact lenses to correct refractive error, if necessary;
  • 500" random dot stereopsis

Exclusion Criteria:

  • Amblyopia (lazy eye);
  • Eye disease
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00472511


Sponsors and Collaborators
Ohio State University
Investigators
Principal Investigator: Levelle Jenkins, OD Ohio State University
Principal Investigator: Marjean Kulp, OD, MS Ohio State University
  More Information

ClinicalTrials.gov Identifier: NCT00472511     History of Changes
Other Study ID Numbers: 2001H0269
First Submitted: May 9, 2007
First Posted: May 11, 2007
Last Update Posted: July 3, 2008
Last Verified: July 2008

Additional relevant MeSH terms:
Ocular Motility Disorders
Central Nervous System Diseases
Nervous System Diseases
Cranial Nerve Diseases
Eye Diseases